Furthermore, this study also showed that METTL3, ICAM2 and p300 levels in RA synovium tissues were related to clinical characteristics and treatment response of RA patients, which supported the role of these target proteins regulated by ATT in RA progression and provided strong evidence for further clinical use of ATT. The gene discussed is ICAM2; the disease is rheumatoid arthritis.